Medical Equipment
35 recent notes from companies in this sector. 13 companies tracked.
Raaj Medisafe CFO quits after Fabrizo deal, raises oversight questions
The resignation of CFO Kanije Fatema Dadani Patel comes just after a transformational acquisition, leaving a nano-cap with thin management depth in a critical moment.
Boston Commerce cancels 95% of equity to wipe out losses
The nano-cap's board approved a scheme that shrinks paid-up capital from ₹7 cr to ₹35 lakh, with no payout to shareholders. The move sets up a cleaner balance sheet but doesn't fix the underlying business.
Boston Commerce, worth ₹4 cr, plans to raise ₹100 cr a year
Nano-cap with negative net worth and a going-concern warning will vote on fundraising, promoter reclassification, and capital reduction, all at a scale several thousand percent of its market cap.
Prevest Denpro's FY26 transcript: nothing new
The full transcript of the June 29 call offers no fresh data vs. the earlier concall summary. A procedural SEBI LODR filing.
Prevest Denpro's FY26 call repeats known numbers; 3D printers shine
Revenue ₹71.81 cr, net profit ₹20.49 cr, both up ~13%. US exports lead. Capacity utilisation on new lines at 18-20% leaves ₹125 cr potential far off.
Boston Commerce revised filing confirms auditor's going concern warning
Assets plunged from ₹1490.37 lakh to ₹76.86 lakh, net worth turns negative at ₹127.15 lakh. Revenue nil, loss of ₹724.11 lakh.
Q-Line Biotech's reagent shift lifts gross margin 750 bps, targets 30-35% growth
FY26 gross margin hits 60.8% as manufactured reagents replace imports; FY27 guidance backed by 300-400 new analyzer installations and ₹10 cr CDMO target.
Nureca hits 2.4M users on health platform, adds AI analytics
Dr Trust 360 crossed 2.4 million users and now offers AI-powered body-composition insights. Yet the press release carries no revenue or subscription numbers.
Saurabh Goyal to own 68% of Nureca after promoter family settlement
Aryan and Payal Goyal transfer their entire 33.7% stake to chairman Saurabh Goyal, who will also take over as CEO after a planned resignation.
Boston Commerce's auditor flags going concern after write-offs wipe out assets
A qualified audit report reveals the auditor initially gave a false clean opinion, which had to be corrected. Virtually all assets are gone, net worth is negative, and shareholders never approved the write-offs.
Shree Pacetronix's joint MD just put ₹2.56 cr of his own money into the stock
Akash Sethi's stake jumped from 8.76% to 13.51% after acquiring 1,78,000 shares in an off-market deal worth ~4.7% of the ₹54 crore company.
Nureca promoter buys 60,842 shares, nudging stake to 34.35%
Saurabh Goyal acquired shares worth ₹1.44 crore off-market, a modest increase in a company with a ₹218 crore market capitalization.
Boston Commerce is writing off assets and shrinking its capital
The ₹5 cr nano-cap has started a balance-sheet cleanup. The numbers are not yet available.
Osel Devices sees FY27 revenue of ₹500 cr after 57% jump
The electronics distributor's profit grew alongside revenue in FY26. Management is now targeting a near-doubling of sales for the next year.
Nureca raised its Punjab plant budget 28%. It calls the first number a typo.
The corrected outlay is ₹128 cr. The initial ₹100 cr disclosure was a mistake, the company says.
Centenial Surgical Suture posts a ₹2.2 cr annual loss on flat revenue
A ₹2.31 crore fourth-quarter loss wiped out the small profit earned through the first nine months. Full-year revenue held flat at ₹53.84 crore.
Centenial Surgical Suture posts FY26 results, auditors sign off clean
A routine annual filing for a nano-cap company. The auditors gave an unmodified opinion, but the results carry no strategic surprises.
Boston Commerce's losses are 44x its market cap. Its auditor flagged unpaid taxes.
The nano-cap's Q4 net loss ballooned to ₹64.58 lakhs. Revenue dropped 60% sequentially. The auditor noted the company failed to pay its TDS dues.
Transpact's revenue doubled to ₹18 lakh. The profit, too.
Full-year revenue jumped to ₹18 lakh from ₹8.25 lakh, with net profit surging to ₹8.64 lakh. The absolute numbers remain minuscule.
Laxmi Dental record revenue, but no new margin target for FY27
Management walked back its 18-20% EBITDA margin guidance, citing a tougher domestic market. The stock must now price in lower profitability.
Nureca posts FY25 results and adds a whole-time director
The board meeting results were already flagged. The new detail is a governance shift at the nano-cap.
Nureca's ₹100 cr capex is 37% of its market cap. The CFO is leaving.
A profit turnaround gives Nureca the credibility to bet big on a Punjab factory. The ₹100 crore capex is a huge commitment for a ₹267 crore company. The CFO exits just as the project starts.
Raaj Medisafe posts FY26 results, addresses routine board items
The nano-cap company filed its annual audited results alongside standard approvals on related-party transactions and preferential allotment fund usage.
GKB Ophthalmics is in default on ₹15.1 cr of bank debt
CRISIL has confirmed a 'D' rating for the lens maker, ending a period of non-cooperation and formalizing the company's default status.
Kretto Syscon revenue halves as FY26 profit drops to ₹201.77 lakhs
The nano-cap firm confirmed audited results showing a sharp decline in annual performance, with Q4 slipping into a loss.
Kretto Syscon revenue halves as annual profit drops to ₹201.77 lakhs
The company reported FY26 revenue of ₹589.89 lakhs, down from ₹1,169.40 lakhs in the prior year, while reserves fell to ₹186.59 lakhs.
Poly Medicure's Q4 profit drops 29% as acquisition costs bite
Consolidated net profit fell 29% in Q4, with standalone down 7%. The results confirm softer trends already flagged in an earlier concall.
Shree Pacetronix's profit surges 300% on leaner balance sheet
Net profit jumped to ₹3.02 crore from ₹75.30 lakhs as borrowings fell and revenue grew 29%.
Shree Pacetronix checks its annual boxes
A routine board meeting approved the FY26 results, auditors, and related-party transactions. No figures were provided.
Poly Medicure walks back PendraCare revenue, renal growth targets
The post-results call corrected a key metric downward and cut a growth forecast, while acquisitions weighed on margins.
Poly Medicure's Q4 profit drops 7% standalone, 29% consolidated on acquisition costs
Standalone net profit slipped to ₹8,062 lacs while consolidated profit took a 29% hit from deal-related expenses. Full-year standalone profit rose just 1.4%.
Poly Medicure profit slips in Q4, hit by acquisition costs
Standalone net profit fell 7% even as revenue grew. On a consolidated basis, profit dropped 29% as acquisition-related expenses weighed.
Laxmi Dental hits record revenue, then pulls FY27 guidance
A strong Q4 was immediately overshadowed by management's refusal to reaffirm profit targets, after missing FY26 margin guidance.
Laxmi Dental re-announces audited Q4 and FY26 results it already filed.
A routine press release adds management narrative to numbers that are already public. The event was the earlier filing.
Laxmi Dental posts 22% revenue growth, but a new labour-law charge hits profit
Standalone profit fell after a ₹51.6 cr exceptional charge for gratuity costs. Revenue and underlying profit both grew strongly.